Oidov Baatarkhuu
Infectious Disease
Ulan Bator, Mongolia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Enhancing access to treatment and programmes for viral hepatitis in an endemic country: a narrative review of literature from 2000 to 2025 (Mongolia).
Journal: Journal of pharmaceutical policy and practice
Published: April 22, 2026
Hepatitis C Virus Infection in Mongolia: Updated Provincial Data on Prevalence, Genotype Distribution, and Age-Specific Risk Factors.
Journal: Viruses
Published: November 03, 2025
Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia.
Journal: Viruses
Published: March 28, 2025
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.
Journal: Hepatology international
Published: September 06, 2024
Global multi-societies endorsement of the MAFLD definition.
Journal: Annals of hepatology
Published: August 07, 2024
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.
Journal: Hepatology international
Published: July 11, 2024
Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN).
Journal: Journal of medical virology
Published: May 14, 2022
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
Journal: Hepatology international
Published: January 08, 2022
The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis.
Journal: Journal of medical virology
Published: September 22, 2021
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
Journal: Hepatology international
Published: March 29, 2021
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
Journal: Hepatology international
Published: June 12, 2020
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study.
Journal: Clinical and molecular hepatology
Published: February 01, 2020
Last Updated: 09/26/2026